We’ve been buying the following names in the past week and selling covered call options.
WFD, GPT and SCG within the REIT space.
You're not a member! Trial today
TCL and SYD defensive infrastructure.
RMD, CSL & SHL as our preferred healthcare exposure.
AMC, BXB and ANN as industrial trades.
IAG & MPL as insurance exposure.
The names above are performing well and in many cases have been the leading ASX companies by % gain, over the past week. Tabcorp on the other hand has been a disappointing inclusion in client portfolios. Our exposure to TAH is only minor, as we don’t view it as a core holding. (rather a tactical trade based around the Tatts deal).
TAH remains within our buy range, although testing the lower band. We continue to feel there’s opportunity ahead. We are again buying TAH at these levels and will look to exit mid year. The upcoming ACCC decision on the Tatts deal, will likely be a positive catalyst and we expect TAH to trade back above $4.60.
The other names mentioned above, have been complimented with a covered call option, which is helping to deliver 10 – 12% cash flow from the option premium and the upcoming dividends.
.
